Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Ticagrelor Effect on Endothelial Function
NCT02910778Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemia-reperfusion injury (IRI) comparing Atorvastatin + Ticagrelor with Placebo + Ticagrelor (2 arms). Primary endpoint: Area under the curve of Forearm blood flow measurements of Acetylcholine induced vasodilatation. Started Oct 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02910778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910778.